Weight loss induced bone loss: mechanism of action and clinical implications
Paccou, J. & Compston, J. E. Bone health in adults with obesity before and after interventions to promote weight loss. Lancet Diabetes Endocrinol. 12, 748–760 (2024).
Beavers, K. M. et al. Effect of exercise modality during weight loss on bone health in older adults with obesity and cardiovascular disease or metabolic syndrome: a randomized controlled trial. J. Bone Miner. Res. 33, 2140–2149 (2018).
Armamento-Villareal, R. et al. Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults. Osteoporos. Int. 25, 551–558 (2014).
Bloomfield, S. A. et al. Exercise training modifies the bone and endocrine response to graded reductions in energy availability in skeletally mature female rodents. Front. Endocrinol. (Lausanne) 14, 1141906 (2023).
Paccou, J., Penel, G., Chauveau, C., Cortet, B. & Hardouin, P. Marrow adiposity and bone: review of clinical implications. Bone 118, 8–15 (2019).
Tencerova, M. et al. The impact of interventional weight loss on bone marrow adipose tissue in people living with obesity and its connection to bone metabolism. Nutrients 15, 4601 (2023).
Hung, C., Muñoz, M. & Shibli-Rahhal, A. Anorexia nervosa and osteoporosis. Calcif. Tissue Int. 110, 562–575 (2022).
Yang, J., Ueharu, H. & Mishina, Y. Energy metabolism: a newly emerging target of BMP signaling in bone homeostasis. Bone 138, 115467 (2020).
Avenell, A., Richmond, P. R., Lean, M. E. & Reid, D. M. Bone loss associated with a high fibre weight reduction diet in postmenopausal women. Eur. J. Clin. Nutr. 48, 561–566 (1994).
Rosas Pereira, A., Costa, M., Costa, G. G. & Carvalho, A. S. Anorexia nervosa and osteoporosis: a possible complication to remember. Cureus 16, e52670 (2024).
Steinman, J. & Shibli-Rahhal, A. Anorexia nervosa and osteoporosis: pathophysiology and treatment. J. Bone Metab. 26, 133–143 (2019).
Nagata, J. M., Golden, N. H., Leonard, M. B., Copelovitch, L. & Denburg, M. R. Assessment of sex differences in fracture risk among patients with anorexia nervosa: a population-based cohort study using the health improvement network. J. Bone Miner. Res. 32, 1082–1089 (2017).
Frolich, J. et al. Assessment of fracture risk in women with eating disorders: The utility of dual-energy x-ray absorptiometry (DXA)-Clinical cohort study. Int. J. Eat. Disord. 53, 595–605 (2020).
Hubel, C. et al. Body composition in anorexia nervosa: Meta-analysis and meta-regression of cross-sectional and longitudinal studies. Int. J. Eat. Disord. 52, 1205–1223 (2019).
Workman, C., Blalock, D. V. & Mehler, P. S. Bone density status in a large population of patients with anorexia nervosa. Bone 131, 115161 (2020).
Faje, A. T. et al. Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radius. J. Clin. Endocrinol. Metab. 98, 1923–1929 (2013).
Singhal, V. et al. Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa. Bone 106, 61–68 (2018).
Frolich, J. et al. The role of body weight on bone in anorexia nervosa: a HR-pQCT study. Calcif. Tissue Int. 101, 24–33 (2017).
Lucas, A. R., Melton, L. J. 3rd, Crowson, C. S. & O’Fallon, W. M. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin. Proc. 74, 972–977 (1999).
Frolich, J. et al. Fractures in women with eating disorders-Incidence, predictive factors, and the impact of disease remission: cohort study with background population controls. Int. J. Eat. Disord. 53, 1080–1087 (2020).
Devlin, M. J. & Rosen, C. J. The bone-fat interface: basic and clinical implications of marrow adiposity. Lancet Diabetes Endocrinol. 3, 141–147 (2015).
Badr, S. et al. Comparison of regional bone marrow adiposity characteristics at the hip of underweight and weight-recovered women with anorexia nervosa using magnetic resonance spectroscopy. Bone 127, 135–145 (2019).
Sen, P. & Uday, S. Bone health in paediatric inflammatory bowel disease. Diagnostics (Basel, Switzerland) 15, 580 (2025).
Collaborators, G. B. D. I. B. D. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 17–30 (2020).
Schule, S. et al. Prediction of low bone mineral density in patients with inflammatory bowel diseases. U. Eur. Gastroenterol. J. 4, 669–676 (2016).
Lo, B. et al. Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease: a Danish population-based inception cohort with 10 years of follow-up. J. Crohns Colitis 14, 904–914 (2020).
Wada, Y. et al. Risk factors for decreased bone mineral density in inflammatory bowel disease: a cross-sectional study. Clin. Nutr. (Edinb., Scotl.) 34, 1202–1209 (2015).
Karnsund, S., Lo, B., Bendtsen, F., Holm, J. & Burisch, J. Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease. World J. Gastroenterol. 26, 5362–5374 (2020).
Sigurdsson, G. V. et al. Young adult male patients with childhood-onset IBD have increased risks of compromised cortical and trabecular bone microstructures. Inflamm. Bowel Dis. 29, 1065–1072 (2023).
Pepe, J. et al. Structural basis of bone fragility in young subjects with inflammatory bowel disease: a high-resolution pQCT study of the SWISS IBD cohort (SIBDC). Inflamm. Bowel Dis. 23, 1410–1417 (2017).
Haschka, J. et al. High-resolution quantitative computed tomography demonstrates structural defects in cortical and trabecular bone in IBD patients. J. Crohns Colitis 10, 532–540 (2016).
Pappa, H. et al. Skeletal health of children and adolescents with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 53, 11–25 (2011).
Marild, K. et al. A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk. Aliment Pharm. Ther. 60, 1549–1560 (2024).
Fink, H. A. et al. Long-term drug therapy and drug discontinuations and holidays for osteoporosis fracture prevention: a systematic review. Ann. Intern Med. 171, 37–50 (2019).
Kim, S. M. et al. Thyrotropin, hyperthyroidism, and bone mass. J. Clin. Endocrinol. Metab. 106, e4809–e4821 (2021).
Hidalgo, D. F., Boonpheng, B., Phemister, J., Hidalgo, J. & Young, M. Inflammatory bowel disease and risk of osteoporotic fractures: a meta-analysis. Cureus 11, e5810 (2019).
Lee, S. Y. & Pearce, E. N. Hyperthyroidism: a review. JAMA 330, 1472–1483 (2023).
Taylor, P. N. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018).
Mudri, D., Bilic Curcic, I., Mestrovic, L., Mihaljevic, I. & Kizivat, T. Hyperthyroidism and Wnt signaling pathway: influence on bone remodeling. Metabolites 13, 241 (2023).
Zhang, Q. et al. intermittent fasting versus continuous calorie restriction: which is better for weight loss? Nutrients 14, 1781 (2022).
Wang, A. & Speakman, J. R. Potential downsides of calorie restriction. Nat Rev. Endocrinol. 21, 427–440 (2025).
Villareal, D. T. et al. Effect of two-year caloric restriction on bone metabolism and bone mineral density in non-obese younger adults: a randomized clinical trial. J. Bone Miner. Res. 31, 40–51 (2016).
Zibellini, J. et al. Does diet-induced weight loss lead to bone loss in overweight or obese adults? a systematic review and meta-analysis of clinical trials. J. Bone Miner. Res. 30, 2168–2178 (2015).
Villareal, D. T., Shah, K., Banks, M. R., Sinacore, D. R. & Klein, S. Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial. J. Clin. Endocrinol. Metab. 93, 2181–2187 (2008).
Herrou, J. et al. Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity. Calcif. tissue Int. 114, 86–97 (2024).
Schoell, S. L. et al. Prediction of lumbar vertebral body compressive strength of overweight and obese older adults using morphed subject-specific finite-element models to evaluate the effects of weight loss. Aging Clin. Exp. Res. 31, 491–501 (2019).
Johnson, K. C. et al. The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial. J. Bone Miner. Res. 32, 2278–2287 (2017).
Villareal, D. T. et al. Reduced bone mineral density is not associated with significantly reduced bone quality in men and women practicing long-term calorie restriction with adequate nutrition. Aging Cell 10, 96–102 (2011).
Devlin, M. J. et al. Caloric restriction leads to high marrow adiposity and low bone mass in growing mice. J. Bone Miner. Res. 25, 2078–2088 (2010).
Devlin, M. J. et al. Daily leptin blunts marrow fat but does not impact bone mass in calorie-restricted mice. J. Endocrinol. 229, 295–306 (2016).
Liu, L. et al. Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling. J. Bone Miner. Res. 39, 1188–1199 (2024).
Behrendt, A. K. et al. Dietary restriction-induced alterations in bone phenotype: effects of lifelong versus short-term caloric restriction on femoral and vertebral bone in C57BL/6 Mice. J. Bone Miner. Res. 31, 852–863 (2016).
Vasim, I., Majeed, C. N. & DeBoer, M. D. Intermittent fasting and metabolic health. Nutrients 14, 631 (2022).
Veronese, N. & Reginster, J. Y. The effects of calorie restriction, intermittent fasting and vegetarian diets on bone health. Aging Clin. Exp. Res. 31, 753–758 (2019).
Clayton, D. J., Varley, I. & Papageorgiou, M. Intermittent fasting and bone health: a bone of contention?. Br. J. Nutr. 130, 1487–1499 (2023).
Kuroda, T., Onoe, Y., Yoshikata, R. & Ohta, H. Relationship between skipping breakfast and bone mineral density in young Japanese women. Asia Pac. J. Clin. Nutr. 22, 583–589 (2013).
Nagata, K. et al. Skipping breakfast and less exercise are risk factors for bone loss in young Japanese adults: a 3-year follow-up study. J. Bone Miner. Metab. 32, 420–427 (2014).
Stekovic, S. et al. Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans. Cell Metab. 30, 462–476 e466 (2019).
Barnosky, A. et al. Effect of alternate day fasting on markers of bone metabolism: An exploratory analysis of a 6-month randomized controlled trial. Nutr. Healthy Aging 4, 255–263 (2017).
Lowe, D. A. et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the Treat randomized clinical trial. JAMA Intern Med. 180, 1491–1499 (2020).
Manoogian, E. N. C. et al. Time-restricted eating in adults with metabolic syndrome: a randomized controlled trial. Ann. Intern Med. 177, 1462–1470 (2024).
Martens, C. R. et al. Short-term time-restricted feeding is safe and feasible in non-obese healthy midlife and older adults. Geroscience 42, 667–686 (2020).
Lobene, A. J. et al. Time-restricted eating for 12 weeks does not adversely alter bone turnover in overweight adults. Nutrients 13, 1155 (2021).
Alrowaili, M. G. et al. Effect of intermittent fasting on glucose homeostasis and bone remodeling in glucocorticoid-induced osteoporosis rat model. J. Bone Metab. 28, 307–316 (2021).
Xu, X. et al. Bone microstructure and metabolism changes under the combined intervention of ketogenic diet with intermittent fasting: an in vivo study of rats. Exp. Anim. 68, 371–380 (2019).
Nauck, M. A., Quast, D. R., Wefers, J. & Meier, J. J. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Mol. Metab. 46, 101102 (2021).
Mabilleau, G., Mieczkowska, A. & Chappard, D. Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials. J. Diabetes 6, 260–266 (2014).
Zhang, Y. S. et al. Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials. Osteoporos. Int. 29, 2639–2644 (2018).
Zhang, Y. S., Zheng, Y. D., Yuan, Y., Chen, S. C. & Xie, B. C. Effects of anti-diabetic drugs on fracture risk: a systematic review and network meta-analysis. Front. Endocrinol. (Lausanne) 12, 735824 (2021).
Cheng, L. et al. Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Metab. Res. Rev. 35, e3168 (2019).
Al Refaie, A. et al. Glucagon-like peptide-1 receptor agonists and diabetic osteopathy: another positive effect of incretines? A 12 months longitudinal study. Calcif. Tissue Int. 115, 160–168 (2024).
Hansen, M. S. et al. Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial. EClinicalMedicine 72, 102624 (2024).
Abo-Elenin, M. H. H., Kamel, R., Nofal, S. & Ahmed, A. A. E. The crucial role of beta-catenin in the osteoprotective effect of semaglutide in an ovariectomized rat model of osteoporosis. Naunyn Schmiedebergs Arch. Pharm. 398, 2677–2693 (2025).
Lv, F., Cai, X., Lin, C., Yang, W. & Ji, L. Effects of semaglutide and tirzepatide on bone metabolism in type 2 diabetic mice. Pharmaceuticals (Basel) 17, 1655 (2024).
Picoli, C. C. et al. Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice. Am. J. Physiol. Endocrinol. Metab. 328, E555–e566 (2025).
Mele, C. et al. Bone response to weight loss following bariatric surgery. Front. Endocrinol. (Lausanne) 13, 921353 (2022).
Mitchell, D. M. et al. Risk of wrist fracture, estimated by the load-to-strength ratio, declines following sleeve gastrectomy in adolescents and young adults. Osteoporos. Int. 35, 285–291 (2024).
Ko, B. J. et al. Relationship between bariatric surgery and bone mineral density: a meta-analysis. Obes. Surg. 26, 1414–1421 (2016).
Rodriguez-Carmona, Y. et al. Bone mineral density after bariatric surgery. A systematic review. Int. J. Surg. 12, 976–982 (2014).
Adamczyk, P. et al. Bone mineral density and body composition after laparoscopic sleeve gastrectomy in men: a short-term longitudinal study. Int. J. Surg. 23, 101–107 (2015).
Hofso, D. et al. Bone mineral density and Turnover After Sleeve Gastrectomy and Gastric Bypass: A Randomized Controlled Trial (Oseberg). J. Clin. Endocrinol. Metab. 106, 501–511 (2021).
Wu, K. C. et al. Skeletal effects of sleeve gastrectomy, by sex and menopausal status and in comparison to Roux-en-Y gastric bypass surgery. medRxiv https://doi.org/10.1101/2024.06.25.24309368 (2024).
Misra, M. et al. Bone outcomes following sleeve gastrectomy in adolescents and young adults with obesity versus non-surgical controls. Bone 134, 115290 (2020).
Maghrabi, A. H. et al. Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy. Obes. (Silver Spring) 23, 2344–2348 (2015).
Ruiz-Tovar, J. et al. Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy. Obes. Surg. 23, 861–866 (2013).
Bredella, M. A. et al. Effects of sleeve gastrectomy on bone marrow adipose tissue in adolescents and young adults with obesity. J. Clin. Endocrinol. Metab. 105, e3961–e3970 (2020).
Paccou, J. et al. Gastric bypass but not sleeve gastrectomy increases risk of major osteoporotic fracture: french population-based cohort study. J. Bone Miner. Res. 35, 1415–1423 (2020).
Chaves Pereira de Holanda, N. et al. Fracture risk after bariatric surgery: a systematic literature review and meta-analysis. Endocr. Pr. 28, 58–69 (2022).
Ivaska, K. K. et al. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Bone 95, 47–54 (2017).
Gagnon, C. & Schafer, A. L. Bone health after bariatric surgery. JBMR 2, 121–133 (2018).
Paccou, J., Caiazzo, R., Lespessailles, E. & Cortet, B. Bariatric surgery and osteoporosis. Calcif. Tissue Int. 110, 576–591 (2022).
Paccou, J. et al. A comparison of changes in bone turnover markers after gastric bypass and sleeve gastrectomy, and their association with markers of interest. Surg. Obes. Relat. Dis. 18, 373–383 (2022).
Weiner, A. et al. The effects of adolescent laparoscopic adjustable gastric band and sleeve gastrectomy on markers of bone health and bone turnover. Clin. Obes. 10, e12411 (2020).
Salman, M. A. et al. Effects of gastric bypass and sleeve gastrectomy on bone mineral density and bone turnover markers: a systematic review and meta-analysis. World J. Surg. 46, 865–875 (2022).
Zhang, S. et al. Effect of exercise on bone mineral density among patients with osteoporosis and osteopenia: A systematic review and network meta-analysis. J. Clin. Nurs. 31, 2100–2111 (2022).
Hong, A. R. & Kim, S. W. Effects of resistance exercise on bone health. Endocrinol. Metab. (Seoul.) 33, 435–444 (2018).
Chang, X., Xu, S. & Zhang, H. Regulation of bone health through physical exercise: Mechanisms and types. Front. Endocrinol. (Lausanne) 13, 1029475 (2022).
Zouhal, H. et al. Effects of exercise training on bone health parameters in individuals with obesity: a systematic review and meta-analysis. Front. Physiol. 12, 807110 (2021).
El Hage, R., Jacob, C., Moussa, E., Youssef, H. & Jaffré, C. Effects of 12 weeks of endurance training on bone mineral content and bone mineral density in obese, overweight and normal weight adolescent girls. Sci. Sports 24, 210–213 (2009).
Kim, Y. S. et al. The effects of aerobic exercise training on serum osteocalcin, adipocytokines and insulin resistance on obese young males. Clin. Endocrinol. (Oxf.) 82, 686–694 (2015).
Berro, A. J., Kazwini, S., Ahmaidi, S. & El Hage, R. Effects of 12 months of resistance training vs. endurance training on bone mineral density, hip geometry indices and trabecular bone score in a group of young overweight women. Sci. Sports 35, 318–319 (2020).
Cunha, P. M. et al. The effects of resistance training volume on osteosarcopenic obesity in older women. J. Sports Sci. 36, 1564–1571 (2018).
Huang, S. W. et al. Body composition influenced by progressive elastic band resistance exercise of sarcopenic obesity elderly women: a pilot randomized controlled trial. Eur. J. Phys. Rehabil. Med. 53, 556–563 (2017).
Choquette, S. et al. Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. Br. J. Nutr. 105, 1199–1209 (2011).
Bolam, K. A., Skinner, T. L., Jenkins, D. G., Galvao, D. A. & Taaffe, D. R. The osteogenic effect of impact-loading and resistance exercise on bone mineral density in middle-aged and older men: a pilot study. Gerontology 62, 22–32 (2015).
Beavers, K. M. et al. Weighted vest use or resistance exercise to offset weight loss-associated bone loss in older adults: a randomized clinical trial. JAMA Netw. Open 8, e2516772 (2025).
Armamento-Villareal, R. et al. Effect of aerobic or resistance exercise, or both, on bone mineral density and bone metabolism in obese older adults while dieting: a randomized controlled trial. J. Bone Miner. Res. 35, 430–439 (2020).
Gerbaix, M. et al. A well-balanced diet combined or not with exercise induces fat mass loss without any decrease of bone mass despite bone micro-architecture alterations in obese rat. Bone 53, 382–390 (2013).
Diniz-Sousa, F. et al. The effect of bariatric surgery on gravitational loading and its impact on bone mass. Bone 153, 116153 (2021).
Soltani, S., Hunter, G. R., Kazemi, A. & Shab-Bidar, S. The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials. Osteoporos. Int. 27, 2655–2671 (2016).
Beavers, D. P. et al. The independent and combined effects of intensive weight loss and exercise training on bone mineral density in overweight and obese older adults with osteoarthritis. Osteoarthr. Cartil. 22, 726–733 (2014).
Shah, K. et al. Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones. J. Bone Miner. Res. 26, 2851–2859 (2011).
Sirola, J. et al. Maintenance of muscle strength may counteract weight-loss-related postmenopausal bone loss-a population-based approach. Osteoporos. Int. 17, 775–782 (2006).
Hammoud, E. et al. Effect of a high-impact exercise program on hip strength indices in a group of obese women after bariatric surgery. J. Clin. Densitom. 28, 101556 (2025).
Courteix, D. et al. Multilevel approach of a 1-year program of dietary and exercise interventions on bone mineral content and density in metabolic syndrome-the RESOLVE randomized controlled trial. PLoS One 10, e0136491 (2015).
Nakata, Y., Ohkawara, K., Lee, D. J., Okura, T. & Tanaka, K. Effects of additional resistance training during diet-induced weight loss on bone mineral density in overweight premenopausal women. J. Bone Miner. Metab. 26, 172–177 (2008).
Mesinovic, J. et al. Exercise attenuates bone mineral density loss during diet-induced weight loss in adults with overweight and obesity: a systematic review and meta-analysis. J. Sport Health Sci. 10, 550–559 (2021).
Liu, L. et al. Calorie restriction induces mandible bone loss by regulating mitochondrial function. Bone 190, 117326 (2025).
Liu, L. & Rosen, C. J. New insights into calorie restriction induced bone loss. Endocrinol. Metab. (Seoul.) 38, 203–213 (2023).
Fogelholm, G. M., Sievanen, H. T., Kukkonen-Harjula, T. K. & Pasanen, M. E. Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women. Osteoporos. Int. 12, 199–206 (2001).
Hyldstrup, L., Andersen, T., McNair, P., Breum, L. & Transbol, I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol. (Copenh) 129, 393–398 (1993).
Liu, H. et al. Bone marrow adipocytes as novel regulators of metabolic homeostasis: clinical consequences of bone marrow adiposity. Curr. Obes. Rep. 14, 9 (2025).
Maio, M. T., Hannan, J. L., Komolova, M. & Adams, M. A. Caloric restriction prevents visceral adipose tissue accumulation and maintains erectile function in aging rats. J. Sex. Med. 9, 2273–2283 (2012).
Avilkina, V. et al. Severity level and duration of energy deficit in mice affect bone phenotype and bone marrow stromal cell differentiation capacity. Front .Endocrinol. (Lausanne) 13, 880503 (2022).
Gómez-Vaquero, C. et al. Bone loss after bariatric surgery is observed mainly in the hip trabecular compartment and after hypoabsorptive techniques. Bone 190, 117270 (2025).
Zhu, J. et al. Short-term caloric restriction induced bone loss in both axial and appendicular bones by increasing adiponectin. Ann. N. Y. Acad. Sci. 1474, 47–60 (2020).
Aaron, N. et al. Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells. Elife 10, e69209 (2021).
Beekman, K. M. et al. The effect of Roux-en-Y gastric bypass on bone marrow adipose tissue and bone mineral density in postmenopausal, nondiabetic women. Obes. (Silver Spring) 29, 1120–1127 (2021).
Bredella, M. A., Greenblatt, L. B., Eajazi, A., Torriani, M. & Yu, E. W. Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue. Bone 95, 85–90 (2017).
Misra, M. & Bredella, M. A. Bone metabolism in adolescents undergoing bariatric surgery. J. Clin. Endocrinol. Metab. 106, 326–336 (2021).
Aalberg, K., Stavem, K., Norheim, F., Russell, M. B. & Chaibi, A. Effect of oral and transdermal oestrogen therapy on bone mineral density in functional hypothalamic amenorrhoea: a systematic review and meta-analysis. BMJ Open Sport Exerc Med. 7, e001112 (2021).
Ayers, J. W., Gidwani, G. P., Schmidt, I. M. & Gross, M. Osteopenia in hypoestrogenic young women with anorexia nervosa. Fertil. Steril. 41, 224–228 (1984).
Biller, B. M. et al. Osteopenia in women with hypothalamic amenorrhea: a prospective study. Obstet. Gynecol. 78, 996–1001 (1991).
Meczekalski, B., Katulski, K., Czyzyk, A., Podfigurna-Stopa, A. & Maciejewska-Jeske, M. Functional hypothalamic amenorrhea and its influence on women’s health. J. Endocrinol. Invest. 37, 1049–1056 (2014).
Bachrach, L. K., Katzman, D. K., Litt, I. F., Guido, D. & Marcus, R. Recovery from osteopenia in adolescent girls with anorexia nervosa. J. Clin. Endocrinol. Metab. 72, 602–606 (1991).
Jones, K. P., Ravnikar, V. A., Tulchinsky, D. & Schiff, I. Comparison of bone density in amenorrheic women due to athletics, weight loss, and premature menopause. Obstet. Gynecol. 66, 5–8 (1985).
Kiriike, N. et al. Reduced bone density and major hormones regulating calcium metabolism in anorexia nervosa. Acta Psychiatr. Scand. 86, 358–363 (1992).
Hui, S. L. et al. Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels. J. Clin. Endocrinol. Metab. 87, 1539–1543 (2002).
Kaur, S. et al. Bone changes post-sleeve gastrectomy in relation to body mass and hormonal changes. Eur. J. Endocrinol. 189, 346–354 (2023).
Ahn, H. J. et al. High risk of fractures within 7 years of diagnosis in Asian patients with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 20, e1022–e1039 (2022).
Sirola, J. et al. Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?. Osteoporos. Int. 14, 27–33 (2003).
Cifuentes, M., Advis, J. P. & Shapses, S. A. Estrogen prevents the reduction in fractional calcium absorption due to energy restriction in mature rats. J. Nutr. 134, 1929–1934 (2004).
Cifuentes, M., Morano, A. B., Chowdhury, H. A. & Shapses, S. A. Energy restriction reduces fractional calcium absorption in mature obese and lean rats. J. Nutr. 132, 2660–2666 (2002).
Hawkins, J., Cifuentes, M., Pleshko, N. L., Ambia-Sobhan, H. & Shapses, S. A. Energy restriction is associated with lower bone mineral density of the tibia and femur in lean but not obese female rats. J. Nutr. 140, 31–37 (2010).
Nattiv, A. et al. American college of sports medicine position stand. The female athlete triad. Med Sci. Sports Exerc. 39, 1867–1882 (2007).
De Prisco, C. & Levine, S. N. Metabolic bone disease after gastric bypass surgery for obesity. Am. J. Med Sci. 329, 57–61 (2005).
Abbasi, A. A. et al. Abnormalities of vitamin D and calcium metabolism after surgical treatment of morbid obesity: a study of 136 patients. Endocr. Pr. 13, 131–136 (2007).
Sperb, L. F., Leotti, V. B., Silveiro, S. P., de Azevedo, M. J. & Viana, L. V. Long-term changes in bone density and bone metabolism after gastric bypass surgery: a retrospective cohort study. Obes. Surg. 33, 911–919 (2023).
Fischer, L. E. et al. Prevalence and risk factors for secondary hyperparathyroidism (SHPT) in patients undergoing bariatric surgery. Surg. Endosc. 37, 8019–8028 (2023).
Balsa, J. A. et al. The role of serum osteoprotegerin and receptor-activator of nuclear factor-κB ligand in metabolic bone disease of women after obesity surgery. J. Bone Miner. Metab. 34, 655–661 (2016).
Blom-Hogestol, I. K. et al. Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass. Bone 127, 436–445 (2019).
Liu, H., Liu, L. & Rosen, C. J. PTH and the regulation of mesenchymal cells within the bone marrow niche. Cells 13, 406 (2024).
Cailleaux, P. E., Ostertag, A., Haguenauer, D. A., Ledoux, S. & Cohen-Solal, M. Long-term differential effects of gastric bypass and sleeve gastrectomy on bone mineral density. J. Endocr. Soc. 8, bvae111 (2024).
Turner, R. T. & Iwaniec, U. T. Low dose parathyroid hormone maintains normal bone formation in adult male rats during rapid weight loss. Bone 48, 726–732 (2011).
Ricci, T. A. et al. Moderate energy restriction increases bone resorption in obese postmenopausal women. Am. J. Clin. Nutr. 73, 347–352 (2001).
Mehler, P. S., Cleary, B. S. & Gaudiani, J. L. Osteoporosis in anorexia nervosa. Eat. Disord. 19, 194–202 (2011).
Swenne, I. & Stridsberg, M. Bone metabolism in adolescent girls with eating disorders and weight loss: independent effects of weight change, insulin-like growth factor-1 and oestradiol. Eat. Weight Disord. 20, 33–41 (2015).
Sukumar, D. et al. Areal and volumetric bone mineral density and geometry at two levels of protein intake during caloric restriction: a randomized, controlled trial. J. Bone Miner. Res. 26, 1339–1348 (2011).
Harris, B. T. et al. Insulin-like growth factor binding protein 2 null mice (Igfbp2-/-) are protected against trabecular bone loss after vertical sleeve gastrectomy. Surg. Endosc. 36, 6984–6996 (2022).
Yakar, S. et al. Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J. Bone Miner. Res. 24, 1481–1492 (2009).
Yakar, S. et al. Circulating levels of IGF-1 directly regulate bone growth and density. J. Clin. Invest. 110, 771–781 (2002).
Brichard, S. M., Delporte, M. L. & Lambert, M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm. Metab. Res. 35, 337–342 (2003).
Conroy, R. et al. Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss. Metabolism 60, 1222–1226 (2011).
Prouteau, S., Benhamou, L. & Courteix, D. Relationships between serum leptin and bone markers during stable weight, weight reduction and weight regain in male and female judoists. Eur. J. Endocrinol. 154, 389–395 (2006).
Madeira, E. et al. Impact of weight loss with intragastric balloon on bone density and microstructure in obese adults. J. Clin. Densitom. 22, 279–286 (2019).
Turner, R. T. et al. Hypothalamic leptin gene therapy reduces body weight without accelerating age-related bone loss. J. Endocrinol. 227, 129–141 (2015).
Maïmoun, L. et al. Effect of nutritional deprivation after sleeve gastrectomy on bone mass, periostin, sclerostin and semaphorin 4D: a two-year longitudinal study. Nutrients 15, 4310 (2023)
Abdeen, G. & le Roux, C. W. Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass. Review. Obes. Surg. 26, 410–421 (2016).
Brzozowska, M. M. et al. Roux-en-Y gastric bypass and gastric sleeve surgery result in long term bone loss. Int. J. Obes. (Lond.) 45, 235–246 (2021).
Carrasco, F. et al. Changes in bone mineral density after sleeve gastrectomy or gastric bypass: relationships with variations in vitamin D, ghrelin, and adiponectin levels. Obes. Surg. 24, 877–884 (2014).
Casimiro, I., Sam, S. & Brady, M. J. Endocrine implications of bariatric surgery: a review on the intersection between incretins, bone, and sex hormones. Physiol. Rep. 7, e14111 (2019).
Jensen, S. B. K. et al. Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment: a secondary analysis of a randomized clinical trial. JAMA Netw. Open 7, e2416775 (2024).
Méquinion, M. et al. Ghrelin: central and peripheral implications in anorexia nervosa. Front. Endocrinol. (Lausanne) 4, 15 (2013).
Wu, K. C. et al. Alteration in the gut microbiome is associated with changes in bone metabolism after laparoscopic sleeve gastrectomy. J. Bone Miner. Res. 39, 95–105 (2024).
Bozadjieva-Kramer, N. et al. Intestinal-derived FGF15 protects against deleterious effects of vertical sleeve gastrectomy in mice. Nat. Commun. 12, 4768 (2021).
Qiao, D. et al. Association of obesity with bone mineral density and osteoporosis in adults: a systematic review and meta-analysis. Public Health 180, 22–28 (2020).
Andersen, B. et al. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys. Int. J. Obes. (Lond.) 42, 1151–1160 (2018).
Bassatne, A., Chakhtoura, M., Saad, R. & Fuleihan, G. E. Vitamin D supplementation in obesity and during weight loss: a review of randomized controlled trials. Metabolism 92, 193–205 (2019).
Canales, B. K., Schafer, A. L., Shoback, D. M. & Carpenter, T. O. Gastric bypass in obese rats causes bone loss, vitamin D deficiency, metabolic acidosis, and elevated peptide YY. Surg. Obes. Relat. Dis. 10, 878–884 (2014).
Corbeels, K. et al. The curious fate of bone following bariatric surgery: bone effects of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in mice. Int. J. Obes. (Lond.) 44, 2165–2176 (2020).
Riedt, C. S. et al. Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake. J. Bone Miner. Res. 20, 455–463 (2005).
Obinwanne, K. M. et al. Effects of laparoscopic Roux-en-Y gastric bypass on bone mineral density and markers of bone turnover. Surg. Obes. Relat. Dis. 10, 1056–1062 (2014).
Jensen, L. B., Kollerup, G., Quaade, F. & Sørensen, O. H. Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation. J. Bone Miner. Res. 16, 141–147 (2001).
Volonakis, S. et al. Adequate vitamin D supplementation does not ameliorate bone loss following long limb-biliopancreatic diversion in morbidly obese women. Hormones (Athens) 20, 315–321 (2021).
Greco, C. et al. Long-term trajectories of bone metabolism parameters and bone mineral density (BMD) in obese patients treated with metabolic surgery: a real-world, retrospective study. J. Endocrinol. Invest. 46, 2133–2146 (2023).
Ben-Porat, T. et al. Bone health following bariatric surgery: implications for management strategies to attenuate bone loss. Adv. Nutr. 9, 114–127 (2018).
Gibson, D., Filan, Z., Westmoreland, P. & Mehler, P. S. Loss of bone density in patients with anorexia nervosa food that alone will not cure. Nutrients 16, 3593 (2024).
Eisenstein, J., Roberts, S. B., Dallal, G. & Saltzman, E. High-protein weight-loss diets: are they safe and do they work? A review of the experimental and epidemiologic data. Nutr. Rev. 60, 189–200 (2002).
Bowen, J., Noakes, M. & Clifton, P. M. A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss. J. Nutr. 134, 568–573 (2004).
Thorpe, M. P. et al. A diet high in protein, dairy, and calcium attenuates bone loss over twelve months of weight loss and maintenance relative to a conventional high-carbohydrate diet in adults. J. Nutr. 138, 1096–1100 (2008).
Boro, H. et al. Bone microarchitecture and bone mineral density in Graves’ disease. Osteoporos. Sarcopenia 9, 70–75 (2023).
Sahin, S. B., Ayaz, T., Sumer, F., Ilkkilic, K. & Algun, E. Bone mineral density in geriatric patients with toxic nodular goiter. Aging Clin. Exp. Res. 27, 221–226 (2015).
Xu, N. et al. Effect of subclinical hyperthyroidism on osteoporosis: a meta-analysis of cohort studies. Endocrine 69, 39–48 (2020).
Kim, D. J., Khang, Y. H., Koh, J. M., Shong, Y. K. & Kim, G. S. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clin. Endocrinol. (Oxf.) 64, 86–90 (2006).
Yang, R. et al. The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies. J. Bone Miner. Metab. 36, 209–220 (2018).
